Fluconazole
Fluconazole Polfarmex belongs to a group of antifungal medicines. The active substance is fluconazole.
Fluconazole Polfarmex is used to treat infections caused by pathogenic fungi and can also be used to prevent yeast infections. The most common cause of fungal infections is yeast of the genus Candida.
The doctor may recommend taking this medicine for the following fungal infections:
Fluconazole Polfarmex can also be used to:
The doctor may recommend taking this medicine to treat the following fungal infections:
Fluconazole Polfarmex can also be used to:
The doctor should be told if:
The doctor or pharmacist should be told about all medicines the patient is taking or plans to take.
The doctor should be told immediatelyabout taking astemizole, terfenadine (antihistamines used to treat allergies), or cisapride (used to treat stomach disorders), or pimozide (used to treat mental disorders), or quinidine (used to treat heart rhythm disorders), or erythromycin (an antibiotic used to treat infections), as they should not be taken with Fluconazole Polfarmex (see section "When not to take Fluconazole Polfarmex").
There are also other medicines that may interact with Fluconazole Polfarmex.
If the patient is taking any of the following medicines, they should make sure their doctor is informed:
The medicine can be taken with or without food.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before taking this medicine.
If the patient plans to become pregnant, it is recommended that after taking a single dose of fluconazole, and before becoming pregnant, they wait for a week. In case of longer treatment cycles with fluconazole, the patient should discuss with their doctor the need to use appropriate contraception during treatment and for a week after the last dose.
If the patient is pregnant, thinks they may be pregnant, or is trying to conceive, they should not take fluconazole unless their doctor recommends it. If the patient becomes pregnant or thinks they may be pregnant while taking this medicine or within one week of taking the last dose, they should contact their doctor.
Fluconazole taken during the first or second trimester of pregnancy may increase the risk of miscarriage. Fluconazole taken during the first trimester of pregnancy may increase the risk of birth defects of the heart, bones, and/or muscles.
There have been reports of children with birth defects of the skull, ears, and thigh and forearm bones, born to mothers treated for coccidioidomycosis with high doses of fluconazole (400-800 mg per day) for at least 3 months. The relationship between fluconazole use and these cases is unclear.
Breastfeeding
The medicine passes into human milk at concentrations lower than in serum. Breastfeeding can be continued after a standard single dose of 200 mg or less. Breastfeeding is not recommended after taking multiple doses of fluconazole or after taking a high dose.
When driving or operating machinery, it should be taken into account that dizziness or seizures may occur occasionally.
Lactose monohydrate
Fluconazole 50 mg contains 0.084 g of lactose monohydrate in one tablet.
Fluconazole 100 mg contains 0.08 g of lactose monohydrate in one tablet.
Fluconazole 150 mg contains 0.12 g of lactose monohydrate in one tablet.
Fluconazole 200 mg contains 0.16 g of lactose monohydrate in one tablet.
This should be taken into account in patients with diabetes. If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
Sodium
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken as recommended by the doctor. In case of doubts, the doctor or pharmacist should be consulted.
The tablet should be swallowed whole, with a glass of water. Tablets are best taken daily at the same time. For children who cannot swallow tablets and for young children, for whom precise dosing based on body weight is necessary, fluconazole is available in syrup form.
Recommended dosing, depending on the type of infection, is presented below.
Indication | Dosage |
Treatment of cryptococcal meningitis | 400 mg on the first day, then 200 mg to 400 mg once a day for 6 to 8 weeks or longer if necessary. Sometimes the dose is increased to 800 mg |
Prevention of relapses of cryptococcal meningitis | 200 mg once a day until the doctor recommends stopping treatment |
Treatment of coccidioidomycosis | 200 mg to 400 mg once a day for 11 months to 24 months or longer if necessary. Sometimes the dose may be increased to 800 mg |
Treatment of internal organ infections caused by Candida yeast | 800 mg on the first day, then 400 mg once a day until the doctor recommends stopping treatment |
Treatment of mucous membrane infections of the mouth, throat, and mouth ulcers related to the use of dental prostheses | 200 mg to 400 mg on the first day, then 100 mg to 200 mg until the doctor recommends stopping treatment |
Yeast infections of the mucous membrane - the dose depends on the location | 50 mg to 400 mg once a day for 7 to 30 days, until the doctor recommends stopping treatment |
Prevention of mucous membrane infections of the mouth and throat | 100 mg to 200 mg once a day, or 200 mg 3 times a week, if the patient is at increased risk of relapse |
Treatment of yeast infections of the genital organs | Single dose of 150 mg |
Prevention of relapses of vaginal yeast infections | 150 mg every third day, for a total of 3 doses (days 1, 4, and 7), and then once a week for 6 months (if the patient is at increased risk of relapse) |
Treatment of fungal skin and nail infections | Depending on the location of the infection, 50 mg once a day, 150 mg once a week, 300 to 400 mg once a week for 1 to 4 weeks (in athlete's foot, treatment may be necessary for up to 6 weeks, in nail infections, treatment should be continued until the old nail is replaced by a new, uninfected one) |
Prevention of yeast infections (if the patient's immune system is weak and does not function properly) | 200 to 400 mg once a day, if the patient is at increased risk of relapse |
The dose prescribed by the doctor should be taken (as for adult patients or as for children).
The maximum dose for children is 400 mg per day.
The dose will be determined based on the child's body weight in kilograms.
Indication | Daily dose |
Yeast infections of the mucous membrane of the mouth and throat - the dose and duration of treatment depend on the severity and location of the infection | 3 mg/kg body weight (on the first day, a dose of 6 mg/kg body weight can be given) |
Cryptococcal meningitis or yeast infections of internal organs | 6 to 12 mg/kg body weight |
Prevention of yeast infections in children (if the immune system does not function properly) | 3 to 12 mg/kg body weight |
The usual dose for adults is given, unless the patient has kidney function disorders.
The doctor may recommend changing the dose, depending on kidney function.
Taking too many tablets at once may cause discomfort. The emergency department of the nearest hospital should be contacted immediately. Symptoms of possible overdose may include hearing, vision, or sensation disorders, thinking about untrue things (hallucinations and paranoid behavior). Symptomatic treatment (life-supporting treatment and stomach lavage, if necessary) may be indicated.
A double dose should not be taken to make up for a missed dose. If a dose is missed, it should be taken as soon as remembered. If it is almost time for the next dose, the missed dose should not be taken.
In case of any further doubts about taking this medicine, the doctor or pharmacist should be consulted.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some patients may experience allergic reactions, but severe allergic reactions are rare. If any of the following symptoms occur, the doctor should be immediatelyinformed:
Fluconazole Polfarmex may affect the liver. Liver-related symptoms include:
If any of the above symptoms occur, the patient should stop taking Fluconazole Polfarmex and immediatelycontact their doctor.
Additionally, if any side effects worsen or any side effects not listed in this leaflet occur, the doctor or pharmacist should be informed.
Common side effects (in 1 to 10 out of 100 patients):
If side effects occur, including any side effects not listed in this leaflet, the doctor or pharmacist should be informed. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Tel.: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the carton and blister or container after: "EXP". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.
Fluconazole Polfarmex is a tablet that is not coated.
Tablets of 50 mg, 100 mg, and 150 mg are white or light cream, round, and convex on both sides.
Tablets of 200 mg are white or light cream, oblong.
Tablets of 50 mg - the packaging contains 3, 7, or 14 tablets.
Tablets of 100 mg - the packaging contains 7 or 28 tablets.
Tablets of 150 mg - the packaging contains 1 or 3 tablets.
Tablets of 200 mg - the packaging contains 7 or 14 tablets.
Polfarmex S.A.
ul. Józefów 9
99-300 Kutno
Poland
Tel.: +48 24 357 44 44
Fax: +48 24 357 45 45
e-mail: polfarmex@polfarmex.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.